🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

NeoGenomics, Inc.

NEO Healthcare
$14.82 $-0.27 (-1.79%)
Market Cap: $1.92 B
Gurus Holding
5
Popularity Rank
#1965
% of Shares Held
0.86%
Net Activity (Q3 2026)
+$3.16 M

Guru Ownership Trend

Guru Analysis for NeoGenomics, Inc. (NEO)

NeoGenomics, Inc. (NEO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.51 M.

Top institutional holders include Cliff Asness and John Hussman.

Institutional sentiment is currently Bullish. This is evidenced by a $3.16 M net inflow during the quarter.

Recent activity highlights John Hussman who opened a new position. Conversely, Cliff Asness reduced exposure by 0.9%.

Key Holders

Top 5 by Value

$15.16 M
$1.93 M
$1.84 M
$933,018
$594,166

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$3.45 M
Total Buy Value
New Buys 3
Additions 0
-$293,480.05
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
3

FAQs for NeoGenomics, Inc. (NEO)

Major holders include Cliff Asness ($15.16 M), John Hussman ($1.93 M), Mario Gabelli ($1.84 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.11 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3.16 M, with 3 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited NEO. The total reported sell value was $293,480.05.

Yes, 3 managers opened new positions in NEO, and 0 increased their existing holdings. The total reported buy value was $3.45 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -0.9% 825,551 $15.16 M Q3 2026
0.41% New Buy 105,000 $1.93 M Q3 2026
0.02% 100,000 $1.84 M Q3 2026
0.00% New Buy 50,818 $933,018 Q3 2026
0.00% New Buy 32,362 $594,166 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form